Status investigation of chronic comorbidity status in elderly at tertiary hospitals and community hospitals

doi:10.3969/j.issn.1004-583X.2021.01.008

Abstract

Abstract:

Objective To understand the status of comorbidity of chronic diseases in elderly people aged ≥60 years and their correlation, so as to provide reference for optimizing the management of comorbidities and formulating the prevention and control measures of comorbidities. Methods Taking a tertiary hospital and community hospital in Tianjin as a pilot, retrospective analysis was involved in the elderly ≥60 years who were hospitalized in the geriatric department of the tertiary hospital and the community hospital. The study collected and compared demographic characteristics including gender, age, and the detection of chronic diseases, etc.Results A total of 950 geriatric inpatients of a tertiary hospital and 14 377 elderly people in community hospitals were included in the study. The detection rates of chronic diseases in the elderly≥60 years in the two hospitals were 94.3% and 57.3%, respectively. The detection rates of hypertension in the two hospitals were 74.1% and 51.9%, respectively, ranking first in chronic diseases(P<0.05). Conclusion The number of elderly patients with comorbidities is huge,and most chronic diseases are related to hypertension. More attention should be paid to the popularization and application of hypertension prevention and treatment strategies, and the construction of networking and interaction between tertiary hospitals and community hospitals should be strengthened to improve the prevention and treatment level of chronic diseases.

Key words: chronic disease, aged, comorbidity, hospitals, community

CLC Number:

R592

Zhang Xinhui, Gu Yumeng, Wang Zhongyan, Wang Donglai, Xia Xiaoshuang, Wang Lin, Liu Xia. Status investigation of chronic comorbidity status in elderly at tertiary hospitals and community hospitals[J]. Clinical Focus, 2021, 36(1): 39-43.

Add to citation manager EndNote|Ris|BibTeX

URL: https://huicui.hebmu.edu.cn/EN/10.3969/j.issn.1004-583X.2021.01.008

https://huicui.hebmu.edu.cn/EN/Y2021/V36/I1/39

Figures/Tables 9

References 20

[1]	Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation[J]. J Chronic Dis, 1987,40(5):373-383. pmid: 3558716
[2]	Gijsen R, Hoeymans N, Schellevis FG, et al. Causes and consequences of comorbidity: A review[J]. J Clin Epidemiol, 2001,54(7):661-674. pmid: 11438406
[3]	徐虎, 范利, 曹丰. 老年共病管理的临床挑战与应对策略[J]. 中华老年多器官疾病杂志, 2019,18(12):942-946.
[4]	李海梅. 农村地区慢性病流行现状及防治对策研究[J]. 现代养生(下半月版), 2016, (11):285.
[5]	李君, 李浩雯, 胡俊斌, 等. 乡村社区老年人慢性病发病状况及其危险因素调查[J]. 中国全科医学, 2012,15(31):3665-3667.
[6]	Marengoni A, Rizzuto D, Wang HX, et al. Patterns of chronic multimorbidity in the elderly population[J]. J Am Geriatr Soc, 2009,57(2):225-230.
[7]	Guisado-Clavero M, Roso-Llorach A, López-Jimenez T, et al. Multimorbidity patterns in the elderly: A prospective cohort study with cluster analysis[J]. BMC Geriatr, 2018,18(1):16.
[8]	陈俊, 胡文彬, 谢辉. 老年原发性高血压患者颈动脉粥样硬化与血压节律及晨峰关系探讨[J]. 心肺血管病杂志, 2020,39(8):928-932.
[9]	Appleton JP, Scutt P, Sprigg N, et al. Hypercholesterolaemia and vascular dementia[J]. Clin Sci (Lond), 2017,131(14):1561-1578.
[10]	Bowles NP, Thosar SS, Herzig MX, et al. Correction to: Chronotherapy for hypertension[J]. Curr Hypertens Rep, 2018,21(1):1.
[11]	刘东亮, 高素颖, 颜应琳, 等. 老年高血压患者颈动脉粥样硬化相关因素分析[J]. 心肺血管病杂志, 2020,39(8):936-941.
[12]	郭雅丽, 姚群英, 梁彩红, 等. 2型糖尿病合并高血压患者外周动脉粥样硬化危险因素分析[J]. 中国实用医药, 2020,15(23):38-40.
[13]	陈四华, 孙旭晖, 袁强. 血清高敏C反应蛋白、脂蛋白相关磷脂酶A2水平与高血压合并冠状动脉粥样硬化性心脏病患者冠状动脉罪犯血管纤维脂质斑块纤维帽厚度的相关性[J]. 中华高血压杂志, 2020,28(7):676-679.
[14]	Zhan C, Shi M, Yang Y, et al. Prevalence and risk factors of carotid plaque among middle-aged and elderly adults in rural Tianjin, China[J]. Sci Rep, 2016,6:23870.
[15]	张祥梅. 健康管理对社区老年慢性病防治的影响[J]. 继续医学教育, 2020,34(9):130-131.
[16]	徐健, 孔灵芝. 关注慢性病助力健康老龄化[J]. 中国慢性病预防与控制, 2020,28(9):641-644.
[17]	Bray N, Kolehmainen N, McAnuff J, et al. Powered mobility interventions for very young children with mobility limitations to aid participation and positive development: the EMPoWER evidence synjournal[J]. Health Technol Assess, 2020,24(50):1-194.
[18]	方张英, 孙海红, 左维佳. 健康管理在老年慢性病患者管理中的应用效果[J]. 中医药管理杂志, 2020,28(17):191-192.
[19]	张冉, 路云, 张闪闪, 等. 中国老年人慢性病共病患病模式及疾病相关性分析[J]. 中国公共卫生, 2019,35(8):1003-1005.
[20]	贾勇, 梅祎祎, 盛楚乔, 等. 55岁及以上城市居民慢性病共病现状调查及相关性分析[J]. 中国全科医学, 2016,19(6):683-687.

组别	例数	性别(例)		年龄[M(QR),岁]
组别	例数	男	女	年龄[M(QR),岁]
三甲医院	950	528	422	66[63, 72]
社区医院	14 377	6 562	7 815	76[68, 84]
统计值		χ²=35.392		U=-25.525
P值		<0.01		<0.01

组别	例数	性别(例)		年龄[M(QR),岁]
组别	例数	男	女	年龄[M(QR),岁]
三甲医院	950	528	422	66[63, 72]
社区医院	14 377	6 562	7 815	76[68, 84]
统计值		χ²=35.392		U=-25.525
P值		<0.01		<0.01

组别	例数	高血压	糖尿病	脑卒中	冠心病	抑郁症	COPD	高脂血症	恶性肿瘤
三甲医院	950	704(74.1)	327(34.4)	641(67.5)	469(49.4)	13(1.4)	21(2.2)	265(27.9)	4(0.4)
社区医院	14 377	7 461(51.9)	2 592(18.0)	751(5.2)	201(1.4)	103(0.7)	184(1.3)	2 541(17.7)	5(0)
χ²值		176.584	155.307	4 181.985	4 905.407	5.043	4.623	62.242	22.657
P值		<0.01	<0.01	<0.01	<0.01	0.025	0.032	<0.01	<0.01

组别	例数	高血压	糖尿病	脑卒中	冠心病	抑郁症	COPD	高脂血症	恶性肿瘤
三甲医院	950	704(74.1)	327(34.4)	641(67.5)	469(49.4)	13(1.4)	21(2.2)	265(27.9)	4(0.4)
社区医院	14 377	7 461(51.9)	2 592(18.0)	751(5.2)	201(1.4)	103(0.7)	184(1.3)	2 541(17.7)	5(0)
χ²值		176.584	155.307	4 181.985	4 905.407	5.043	4.623	62.242	22.657
P值		<0.01	<0.01	<0.01	<0.01	0.025	0.032	<0.01	<0.01

慢性病	年龄段				χ²值	P值
慢性病	60~69岁(n=287)	70~79岁(n=276)	80~89岁(n=317)	≥90岁(n=70)	χ²值	P值
高血压	226(78.7)	210(76.1)	228(71.9)	40(57.1)	15.067	<0.01
糖尿病	109(38.0)	95(34.4)	105(33.1)	18(25.7)	4.197	>0.05
脑卒中	194(67.6)	209(75.7)	207(65.3)	31(44.3)	26.396	<0.01
冠心病	100(34.8)	136(49.3)	195(61.5)	38(54.3)	43.611	<0.01
抑郁症	7(2.4)	4(1.4)	2(0.6)	-	4.699	>0.05
COPD	3(1.0)	5(1.8)	11(3.5)	2(2.9)	4.468	>0.05
高脂血症	118(41.1)	76(27.5)	66(20.8)	5(7.1)	47.832	<0.01
恶性肿瘤	1(0.3)	-	3(0.9)	-	3.586	>0.05